In addition to the well-documented effect of plasma gelsolin in trauma injuries, sepsis, infections, and neurological disorders, single studies present the potential of pGSN in other diseases, including diabetes [31], pre-eclampsia [171], congenital genetic syndromes [172], or rhabdomyolysis [173]. This evidence concerns the gene GSN and nervous system disorder.